Lee holds over 25 years’ experience in healthcare and technology sectors in both public ASX and private enterprises, holding multiple executive leadership roles.
Prior to joining LTR Pharma, Lee worked at Fortescue Metals group and was CEO and managing director for healthcare technology spin out Allied Medical, leading it to a valuation peak of $250m from $800k.
Lee has a proven record of commercialising medical devices in Australia, North America, Europe and Asia with significant experience in Nasal Spray product sales
Julian holds over 20 years’ experience in healthcare and biotechnology sectors across ASX-listed companies, investment banking, and private equity.
Julian is currently CEO of ReNerve Ltd (ASX:RNV) and has held senior executive and board positions including at ASX-listed companies Avexa (ASX:AVX) and Admedus (ASX:AHZ, AVR). He served as Chair of Opyl Limited (ASX:OPL) and Deputy Chair of Cann Group Ltd.
Julian has significant expertise in healthcare investment analysis, corporate strategy, and commercialisation of medical technologies.
Maja holds over 15 years’ experience at board and senior management level across healthcare, mining, and technology sectors in both ASX-listed and private companies.
Prior to her current board roles, Maja was General Counsel and Company Secretary of US-based Anteris Technologies Ltd (ASX:AVR) and Alexium International Group Ltd (ASX:AJC), leading strategy and corporate development for both growth-stage and mature organisations.
Maja has proven expertise in corporate governance, legal and regulatory affairs, and strategic transformation. She currently serves as Non-Executive Chair of TechGen Metals Ltd (ASX:TG1).